ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2044

Abnormalities of Extracellular Matrix Modeling Gene Expression in Salivary Gland Epithelial Cells of Patients with Sjögren’s Syndrome

Elodie Riviere1, Juliette Pascaud1, Franck Letourneur2, Gaetane Nocturne3 and Xavier Mariette4, 1Université Paris-Saclay, INSERM U1184, Le Kremlin Bicêtre, France, 2Genomic, Hôpital Cochin, Université Paris Descartes, Sorbonne Paris Cité, Paris, France, 3APHP, Le Kremlin Bicêtre, France, 4Paris-Saclay University, Rueil Malmaison, Ile-de-France, France

Meeting: ACR Convergence 2022

Keywords: Collagen, Gene Expression, Metalloproteinase, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Sjögren's Syndrome – Basic and Clinical Science Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Salivary gland epithelial cells (SGECs) are not only the target of autoimmunity in primary Sjögren’s syndrome (pSS). SGECs may interact with lymphocytes and therefore participate to the over activation of the immune system (1). Moreover, SGECs may undergo TGFb mediated epithelial to mesenchymal transition during pSS (2).

We aimed to determine whether SGECs from pSS present intrinsic abnormalities that may be involved in pSS pathogenesis, especially concerning their potential role in salivary gland microenvironment modifications.

Methods: Minor salivary gland (MSG) biopsies were obtained from patients referred for suspicion of pSS to the Rheumatology Department of Bicêtre hospital, AP-HP, Université Paris-Saclay, a tertiary reference center for systemic auto-immune diseases. pSS was defined according to the 2016 ACR/EULAR criteria. RNAseq analysis of primary SGECs (5 controls and 5 pSS) was performed after 2-3 weeks of culture (Illumina). Statistical analyses on the read counts were performed with the DESeq2 package. Absolute FC value >1.5 and p-value< 0.05 was applied to identify up and down-regulated genes. Confirmation RT-qPCR were then performed on additional SGECs samples (n = 15 controls and 13 pSS).

Results: RNAseq analysis of SGECs from pSS compared to controls identified 251 upregulated and 260 downregulated genes. Functional enrichment pathway analysis highlighted an over-representation of the Inhibition of Matrix Metalloproteases signaling pathway (Table1). Among the most upregulated genes, using string DB software, we identified hubs corresponding to genes involved in extracellular matrix formation, such as collagen genes and ADAMTS genes (Figure 1). RT-qPCR allowed to confirm the upregulation of COL3A1 in SGECs from pSS compared to controls (Figure 2A). Interestingly, among the other upregulated genes in RNAseq, MMP24 was significantly higher in SGECs from pSS with a focus score (FS) >1 on MSG biopsy than pSS with a FS < 1 (Figure 2B). We hypothesized that SGECs may undergo epithelial-mesenchymal transition (EMT) during pSS. We looked at EMT transcription factors, and observed a trend for an up regulation of SNAI1 (coding for SNAIL) and ZEB2, and for a down regulation of SLUG in SGECs from pSS with FS >1 compared to pSS with a FS< 1 (Figure 2B). Interestingly, there was an inverse correlation between SLUG expression and the focus score in SG, and we also observed a correlation between ZEB2 expression and the focus score (Figure 2C)

Conclusion: We found an increased expression of Matrix Metalloproteases signaling pathway and a trend for increased expression of several genes involved in EMT between pSS and controls. Thus, besides a role in immune cells activation, we found another possible pathogenic role of SGECs in pSS through the induction of SG fibrosis development. The correlation between genes involved in EMT expression and lymphocytic infiltrates in the SG suggests that the crosstalk between SGECs and lymphoid cells could be bi-directional from SGECs to immune cells, but also from immune cells to SGECs.

References:
1. Rivière E, et al., Ann Rheum Dis. 2020
2. Sisto M, et al. Arch Immunol Ther Exp. 2020

Supporting image 1

Table 1

Supporting image 2

Figure 1

Supporting image 3

Figure 2


Disclosures: E. Riviere, None; J. Pascaud, None; F. Letourneur, None; G. Nocturne, Pfizer, Novartis, Eli Lilly, Amgen; X. Mariette, AstraZeneca, Bristol Myers Squibb, Galapagos, GSK, Novartis, Pfizer.

To cite this abstract in AMA style:

Riviere E, Pascaud J, Letourneur F, Nocturne G, Mariette X. Abnormalities of Extracellular Matrix Modeling Gene Expression in Salivary Gland Epithelial Cells of Patients with Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/abnormalities-of-extracellular-matrix-modeling-gene-expression-in-salivary-gland-epithelial-cells-of-patients-with-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abnormalities-of-extracellular-matrix-modeling-gene-expression-in-salivary-gland-epithelial-cells-of-patients-with-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology